INNATE PHARMA: ifrs:AdjustmentsForFinanceCosts
| Value | {"amount": 341000.0} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T01:40:47.803569+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/2a4f9481-c52e-4f80-abe5-92f4dece50d5
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2021-12-31Retrieved: 2026-08-24T01:40:47.803569+02:00
Raw response sha256:
42626ba7b8f480e2f866e4e74f892a57…Cite as: FACTANKER, https://factanker.com/fact/2a4f9481-c52e-4f80-abe5-92f4dece50d5
History
- no predecessors — first report